Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Krystal Biotech Inc., 3 years.
Krystal Biotech Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Krystal Biotech Inc. | Open-market sale | −9,430 | $275.45 | $2,597,494 |
| Feb 27, 2026 | Krystal Biotech Inc. | Open-market sale | −2,373 | $276.17 | $655,351 |
| Feb 26, 2026 | Krystal Biotech Inc. | Open-market sale | −5,103 | $275.28 | $1,404,754 |
| Feb 26, 2026 | Krystal Biotech Inc. | Open-market sale | −2,638 | $276.32 | $728,932 |
| Feb 25, 2026 | Krystal Biotech Inc. | Open-market sale | −700 | $275.00 | $192,500 |
| Feb 24, 2026 | Krystal Biotech Inc. | Option exercise | +37,895 | $2.46 | $93,222 |
| Feb 24, 2026 | Krystal Biotech Inc. | Open-market sale | −569 | $262.91 | $149,596 |
| Feb 24, 2026 | Krystal Biotech Inc. | Open-market sale | −1,733 | $264.12 | $457,720 |
| Feb 24, 2026 | Krystal Biotech Inc. | Open-market sale | −3,557 | $265.08 | $942,890 |
| Feb 24, 2026 | Krystal Biotech Inc. | Open-market sale | −8,986 | $266.18 | $2,391,893 |
| Feb 24, 2026 | Krystal Biotech Inc. | Open-market sale | −11,673 | $266.97 | $3,116,341 |
| Feb 24, 2026 | Krystal Biotech Inc. | Open-market sale | −6,671 | $268.04 | $1,788,095 |
| Feb 24, 2026 | Krystal Biotech Inc. | Open-market sale | −3,963 | $268.97 | $1,065,928 |
| Feb 24, 2026 | Krystal Biotech Inc. | Open-market sale | −370 | $269.83 | $99,837 |
| Feb 24, 2026 | Krystal Biotech Inc. | Open-market sale | −373 | $271.09 | $101,117 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.